Rebeca Rodríguez-Veiga

13PUBLICATIONS
94CO-AUTHORS
Haematological tumoursOtorhinolaryngologyCardiovascular medicine and haematology not elsewhere classifiedTransplantation immunologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 07, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

|Apr 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

|Feb 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Sep 13, 2025
Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study.

Antonio Solana-Altabella, Irene Navarro-Vicente, Eduardo Rodríguez-Arbolí

|Sep 01, 2025
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry.

Ana Alfonso-Pierola, David Martinez-Cuadrón, Rebeca Rodríguez-Veiga

|Aug 14, 2025
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Laura Torres-Miñana, Blanca Boluda, Antonio Solana-Altabella

Pageof 3

Frequent Collaborators

11 joint publications

Pau Montesinos

10 joint publications

David Martínez-Cuadrón

7 joint publications

Juan Miguel Bergua-Burgues

6 joint publications

Lorenzo Algarra-Algarra